Benjamin Castleman
Benjamin Castleman (1906–1982) was an American pathologist who is best known for his description of Castleman disease, a rare lymphoproliferative disorder. He made significant contributions to the field of pathology and was a prominent figure in medical research during his career.
Early Life and Education[edit | edit source]
Benjamin Castleman was born in 1906. He pursued his medical education at Yale University, where he earned his medical degree. Following his graduation, Castleman completed his residency in pathology at the Massachusetts General Hospital (MGH) in Boston, where he would later spend much of his professional career.
Career[edit | edit source]
Castleman joined the faculty at Harvard Medical School and became a leading figure in the Department of Pathology at Massachusetts General Hospital. His work primarily focused on the study of lymphoid tissues and diseases.
Castleman Disease[edit | edit source]
In 1954, Castleman first described a condition that would later bear his name, Castleman disease. This disease is characterized by non-cancerous growths that can develop in the lymph node tissue. There are two main types of Castleman disease: unicentric and multicentric. Unicentric Castleman disease affects a single lymph node, while multicentric Castleman disease involves multiple lymph nodes and can have more severe systemic symptoms.
Contributions to Pathology[edit | edit source]
Castleman's research extended beyond Castleman disease. He made numerous contributions to the understanding of various lymphoproliferative disorders and other pathological conditions. His work has had a lasting impact on the field of pathology and has influenced subsequent research and clinical practices.
Legacy[edit | edit source]
Benjamin Castleman passed away in 1982, but his legacy continues through the ongoing research and treatment of Castleman disease and other lymphoproliferative disorders. His contributions to medical science are commemorated by the continued use of his name in the disease he first described.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
